TokenPost·
Exagen Maintains 2026 Revenue Outlook at $72 Million to $75 Million
Its myositis offering remains on track for an early 2027 launch.
More news
- TokenPostInfinity Natural Resources Narrows 2026 Production and Spending Guidance
- Crypto BriefingSolana Mobile names Helius and Jito as first independent dApp Store Guardians
- TokenPostBank of Canada Council Says Policy Can Curb Energy Price Spillover
- TokenPostTokenized Stocks Grow 894% Year Over Year to $4.8 Billion in Value
- TokenPostAMD Shows Creative Workflows on Ryzen AI Max Systems at Adobe MAX
- TokenPostChicago Atlantic Sees $0.015 Distributable Earnings Lift Per 25-Basis-Point Rate Increase